| Literature DB >> 23173617 |
Chenxing Liu1, Fuquan Zhang, Tingting Li, Ming Lu, Lifang Wang, Weihua Yue, Dai Zhang.
Abstract
BACKGROUND: Numerous single nucleotide polymorphisms (SNPs) associated with complex diseases have been identified by genome-wide association studies (GWAS) and expression quantitative trait loci (eQTLs) studies. However, few of these SNPs have explicit biological functions. Recent studies indicated that the SNPs within the 3'UTR regions of susceptibility genes could affect complex traits/diseases by affecting the function of miRNAs. These 3'UTR SNPs are functional candidates and therefore of interest to GWAS and eQTL researchers. DESCRIPTION: We developed a publicly available online database, MirSNP (http://cmbi.bjmu.edu.cn/mirsnp), which is a collection of human SNPs in predicted miRNA-mRNA binding sites. We identified 414,510 SNPs that might affect miRNA-mRNA binding. Annotations were added to these SNPs to predict whether a SNP within the target site would decrease/break or enhance/create an miRNA-mRNA binding site. By applying MirSNP database to three brain eQTL data sets, we identified four unreported SNPs (rs3087822, rs13042, rs1058381, and rs1058398), which might affect miRNA binding and thus affect the expression of their host genes in the brain. We also applied the MirSNP database to our GWAS for schizophrenia: seven predicted miRNA-related SNPs (p < 0.0001) were found in the schizophrenia GWAS. Our findings identified the possible functions of these SNP loci, and provide the basis for subsequent functional research.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23173617 PMCID: PMC3582533 DOI: 10.1186/1471-2164-13-661
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Workflow depicting analysis of variations in/near miRNA genes.
Figure 2Density of SNPs in human miRNA genes. (A) SNP density in human pre-miRNAs and flanking regions. Each bar represents the average level of all human miRNAs, error bars represent the standard deviation of the mean value. MiRNA and SNP information came from mirBASE18 and dbSNP135, respectively. Figure A shows the result of all SNPs in dbSNP135. (B) Figure B only shows SNPs with a calculated MAF > 0.01 in at least one population from four (CEU, HCB, JPT, YRI).
Figure 3(A) Workflow depicting the analysis of variations in miRNA-mRNA binding sites.(B) An example of how we determinate a SNP in predicted mRNA target site.
Figure 4(A) The “Single search” frame of the MirSNP web site. (B) An example of miRNA-related SNP search results.
Figure 5The “Query disease & trait associated SNPs” frame of the MirSNP web site.
Brain eQTLs found in predicted miRNA-mRNA binding sites
| rs3087822 | CRIPT | hsa-miR-200a-3p, hsa-miR-26b-3p, hsa-miR-29b-1-5p, hsa-miR-335-3p | A/G | rs3087822 | 1 | 8.45E-05 | 9.54E-18 | 3.20E-13 |
| rs13042 | FAM82B | hsa-miR-202-5p, hsa-miR-362-5p, hsa-miR-500b, hsa-miR-1914-5p | A/Ge | rs13042/rs4961193 | 1/0.864 | 5.03E-06 | 8.52E-16 | 1.30E-08 |
| rs1058381 | RABEP1 | hsa-miR-4760-3p | A/G | rs1058381/rs1065483 | 1/0.954 | 0.00254 | 7.81E-19 | 2.89E-08 |
| rs1058398 | RABEP1 | hsa-miR-134, hsa-miR-3118, hsa-miR-943, hsa-miR-192-3p, hsa-miR-5002-3p | A/G | rs1065483 | 0.955 | 0.00254 | 7.81E-19 | 3.92E-10 |
aLinkage analysis of predicted miRNA-related SNPs and eQTLs in 90 CEU individuals from HapMap project.
bA survey of gene expression of 193 normal human brain tissues (cortex) [22]. The p-values have been adjusted by Bonferroni correction.
cA survey of gene expression of 269 normal human brain tissues (prefrontal cortex) [23]. Genome-wide Bonferroni corrected p = 0.05 (2.6e-12).
dA survey of gene expression of 150 normal human brain tissues (cerebellum, frontal cortex, pons, and temporal cortex) [24].
eAlthough rs13042 has four allelotypes in MirSNP, only A and G alleles have frequencies in populations.
Putative miRNA-related SNPs associated with schizophrenia
| rs11178988 | TBC1D15 | 0.156 | hsa-miR-145-3p, hsa-miR-3680-3p, hsa-miR-5689, hsa-miR-1294 | C/T | rs17110426 | 0.945521 | 4.06E-06 | 0.6449 |
| rs11178989 | TBC1D15 | 0.156 | hsa-miR-4501 | A/C | rs17110426 | 0.945521 | 4.06E-06 | 0.6449 |
| rs17110432 | TBC1D15 | 0.167 | hsa-miR-1193, hsa-miR-335-3p, hsa-miR-29b-2-5p | A/G | rs17110426 | 1 | 4.06E-06 | 0.6449 |
| rs11544338 | FAM117B | 0.305 | hsa-miR-409-3p, hsa-miR-653 | A/C/G/T | rs11544338 | 1 | 5.48E-06 | 0.6511 |
| rs11680951 | FAM117B | 0.291 | hsa-miR-516a-3p, hsa-miR-376a-5p, hsa-miR-1287, hsa-miR-145-3p, hsa-miR-5191, hsa-miR-516b-3p | A/C/G/T | rs11544338 | 1 | 5.48E-06 | 0.6511 |
| rs6058896 | DNMT3B | 0.078 | hsa-miR-30b-5p, hsa-miR-3686, hsa-miR-30c-5p, hsa-miR-4773, hsa-miR-2278, hsa-miR-589-3p | C/T | rs6058894 | 0.946365 | 2.31E-05 | 1.584 |
| rs10484565 | TAP2 | 0.078 | hsa-miR-3689b-5p, hsa-miR-3177-5p, hsa-miR-3689a-5p, hsa-miR-3689f, hsa-miR-190b, hsa-miR-3689e, hsa-miR-190a | A/G | rs10484565 | 1 | 3.58E-05 | 1.448 |
| rs670358 | CDC42BPG | 0.395 | hsa-miR-4305, hsa-miR-331-3p, hsa-miR-4638-3p, hsa-miR-4705, hsa-miR-3690, hsa-miR-5195-5p, hsa-miR-4308 | A/G | rs670358 | 1 | 4.68E-05 | 0.7677 |
| rs11563929 | STEAP2 | 0.1 | hsa-miR-16-2-3p, hsa-miR-195-3p, hsa-miR-3942-5p, hsa-miR-4703-5p, hsa-miR-4766-3p | G/T | rs11563929 | 1 | 6.81E-05 | 0.7281 |
| rs16870907 | TAP2 | 0.047 | hsa-miR-4760-3p, hsa-miR-330-3p | C/T | rs16870907 | 1 | 8.48E-05 | 1.589 |
| rs12178 | ZBTB34 | 0.456 | hsa-miR-1267, hsa-miR-501-5p, hsa-miR-3613-3p, hsa-miR-653 | A/C/G/T | rs12178 | 1 | 9.66E-05 | 1.277 |
Eleven putative miRNA-related SNPs link to SCZ-GWAS SNPs with a significance of p < 0.0001.
aMinor allele frequencies (MAF) are from an HCB population.
bAllele reports are from NCBI.
cLinkage analysis of putative miRNA-related SNPs and SCZ-associated SNPs in 90 Asian individuals from the HapMap project.
Comparison among four databases
| | ||||
| Results | ||||
| miRNA-related SNPs | 414510 | 117037 | 19513 | 26578 |
| miRNA-related SNPs with MAF > 0.01 | 32822 | 21938 | 19208 | 7334 |
| Involved Genes | 17569 | 13129 | 8495 | 11314 |
| Involved mature miRNAs | 1921 | 1738 | 1222 | 846 |
| Records (SNPs with MAF > 0.01) | 121796 | 78351 | 69026 | 10908 |
| Overlap with MirSNP | ||||
| Number of SNPs (MAF > 0.01) coinciding with MirSNP | 15913 | 17481 | 5759 | |
Figure 6Comparison between MirSNP and three similar databases.
Experimentally validated miRNA-related SNPs found in MirSNP
| hsa-mir-629 | NBS1 | rs2735383 | Lung cancer | | | | | 22114071 | Carcinogenesis | Yang L |
| hsa-mir-184 | TNFAIP2 | rs8126 | Squamous cell carcinoma of the head and neck | ✓ | ✓ | | | 21934093 | Carcinogenesis | Liu Z |
| hsa-mir-1827 | MYCL1 | rs3134615 | Small-cell lung cancer | ✓ | | ✓ | ✓ | 21676885 | Cancer Res | Xiong F |
| hsa-mir-148a | HLA-C | rs67384697 | HIV | ✓ | | | | 21499264 | Nature | Kulkarni S |
| hsa-mir-191 | MDM4 | rs4245739 | Ovarian carcinomas | ✓ | | ✓ | | 21084273 | Cancer Res | Wynendaele J |
| hsa-mir-125b | BMPR1B | rs1434536 | Breast cancer | ✓ | ✓ | ✓ | ✓ | 19738052 | Cancer Res | Saetrom P |
| hsa-mir-510 | HTR3E | rs56109847 | Diarrhea predominant irritable bowel syndrome | ✓ | ✓ | | | 18614545a | Hum. Mol. Genet | Kapeller J |
| hsa-mir-96 | HTR1B | rs13212041 | Arson or property damage | | | | | 18283276a | Mol. Psychiatry | Jensen KP |
| hsa-mir-433 | FGF20 | rs12720208 | Parkinson’s disease | ✓ | | ✓ | | 18252210a | Am. J. Hum. Genet | Wang G |
| hsa-mir-148/152 | HLA-G | rs1063320 | Childhood asthma | ✓ | ✓ | ✓ | ✓ | 17847008a | Am. J. Hum. Genet | Tan Z |
| hsa-mir-24 | DHFR | rs34764978 | Methotrexate resistance | | | | | 17686970a | PNAS | Mishra PJ |
| hsa-mir-155 | AGTR1 | rs5186 | Hypertension | ✓ | ✓ | | | 17668390a | Am. J. Hum. Genet | Sethupathy P |
| hsa-mir-206 | ESR1 | rs9341070 | Breast cancer | | | | | 17312270a | Mol. Endocrinol | Adams BD |
| hsa-mir-24 | SLITRK1 | rs193302862 | Tourette’s syndrome | ✓ | 16224024a | Science | Abelson JF |
Some cases are not in MirSNP because the SNPs were not located in the 3’UTR based on our records (rs34764978, rs13212041) or do not have a perfect 7-nt binding in the seed site (rs2735383, rs9341070).
aThese cases are from Table 2 in Sethupathy and Collins [34].